As shown in Table 1; the use of LYC at the doses of 2.5 and 5 mg/kg bw significantly reduced (p < 0.05) the ALT, AST, LDH and MDA values after hepatic ischemia/reperfusion (ALT 11.39 and 23.42 %, AST 8.62 and 28.21 %, LDH 19.50 and 33.08 %, MDA 15.75 and 26.14 %, respectively) when compared to IR-C group. Here, GPT is linked to ischemia.